Approved ClaimAnchor MVP scope

Synthetic/demo data only. Human review required. No claim submission, no mobile app work, and no production or external integrations are enabled in this build.

Included

Web-first intake and start flow
Claim issue builder
Evidence prompts and checklist generation
Advisor-ready summary and handoff preview
Rating movement preview and pyramiding warnings
Tenant-configurable referral foundation

Excluded

Mobile apps
Claim submission
Legal advice or final medical determinations
Live VNCC/Pipedrive or production API integrations
Real client/veteran data
Autonomous sending, publishing, or deployment

Working Intake Flow

Draft saves locally in this browser. Current step: current-rating. This prototype now uses guided branching so irrelevant paths are hidden instead of asking impossible questions.

Claim Path Triage

Have you filed a VA disability claim before?

If No, ClaimAnchor skips current-rating, increase, and appeal-denial questions.

Do you currently have any VA disability ratings?

Do you have a recent VA decision letter?

Branching status

Current VA rating questions: Shown

Visible because prior claim/rating information may exist.

Decision review questions: Hidden

Hidden until a decision letter exists and review/appeal is requested.

Increase path questions: Hidden

Hidden because an increase requires an already service-connected condition.

Secondary path questions: Shown

Visible because a rated condition may support secondary analysis.

Display name

Email

State

Primary goal

Service History

Branch

Entry month/year

Separation month/year

Occupation / role

Current Snapshot

Combined percent, if known

Actual combined known?

Issues to Review

Issue 1

Condition or issue name

Review type

Already listed?

Current percent, if known

Brief explanation

Treatment source

Functional impact

Evidence Placeholders

Recent decision letter Current status list Treatment records

Advisor Summary Preview

Potential increases: 0

Secondary review: 0

Appeal/reduction: 0

Missing evidence: 2

Human review priority: high